Zevra Therapeutics Inc (ZVRA)

R&D to Revenue

11.31%

Quarterly · Period ending:

ZVRA logo

ZVRA R&D to Revenue

Latest reported11.31%
ZVRA Quarterly R&D/Revenue (0.00% → 11.31%)
High-resolution chart · PNG

ZVRA r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
11.3103%
12.1259%
7.6777%
13.1681%
13.2646%
15.9698%
82.3217%
296.2111%
236.4801%
312.8467%
79.027%
424.7668%
87.7568%
272.5126%
-487.7533%
187.3695%
1,727.5385%
77.7301%
108.7916%
113.944%
23.7611%
18.6927%
129.0786%
88.7792%
28.286%
101.7712%
179.1424%
31.545%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.